1111 related articles for article (PubMed ID: 6263995)
21. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.
van Cromvoirt SM; Thomas CM; Quinn MA; McNally OM; Bekkers RL
Gynecol Oncol; 2014 Jun; 133(3):542-5. PubMed ID: 24631700
[TBL] [Abstract][Full Text] [Related]
22. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
Morrow P; Nakamura R; Schlaerth J; Gaddis O; Eddy G
Am J Obstet Gynecol; 1985 Apr; 151(7):906-14. PubMed ID: 2580438
[TBL] [Abstract][Full Text] [Related]
23. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
24. Follow-up after hydatidiform mole: studies using radioimmunoassay for urinary human chorionic gonadotrophin (HCG).
Bagshawe KD; Wilson H; Dublon P; Smith A; Baldwin M; Kardana A
J Obstet Gynaecol Br Commonw; 1973 May; 80(5):461-8. PubMed ID: 4351453
[No Abstract] [Full Text] [Related]
25. [Prevention of the malignant form of trophoblastic disease after a hydatidiform mole: systematic or selective chemotherapy].
Delvoye P; Robyn C
J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):267-93. PubMed ID: 181422
[TBL] [Abstract][Full Text] [Related]
26. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
27. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
Tscherne G; Pürstner P
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of hydatidiform mole and choriocarcinoma.
Bracken MB; Brinton LA; Hayashi K
Epidemiol Rev; 1984; 6():52-75. PubMed ID: 6386504
[TBL] [Abstract][Full Text] [Related]
29. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
[TBL] [Abstract][Full Text] [Related]
30. Cytological distribution of chorionic gonadotropin subunit and placental lactogen messenger RNA in neoplasms derived from human placenta.
Hoshina M; Hussa R; Pattillo R; Boime I
J Cell Biol; 1983 Oct; 97(4):1200-6. PubMed ID: 6619191
[TBL] [Abstract][Full Text] [Related]
31. Immobilized Datura stramonium agglutinin column chromatography, a novel method to discriminate the urinary hCGs of patients with invasive mole and choriocarcinoma from those of normal pregnant women and patients with hydatidiform mole.
Endo T; Iino K; Nozawa S; Iizuka R; Kobata A
Jpn J Cancer Res; 1988 Feb; 79(2):160-4. PubMed ID: 3130349
[TBL] [Abstract][Full Text] [Related]
32. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
33. [Molecular weight and fragmentation of human chorionic gonadotropin in urine in patients with trophoblastic diseases].
Ide K; Nishimura R; Kitajima T; Utsunomiya T; Tanabe K; Yuki Y; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Feb; 40(2):160-6. PubMed ID: 2834473
[TBL] [Abstract][Full Text] [Related]
34. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
35. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
36. Characterization of human chorionic gonadotropin in urine of patients with trophoblastic diseases by Western blotting using specific antibodies.
Nishimura R; Utsunomiya T; Ide K; Kitajima T; Chen HC; Strobel JL; Hussa RO; Mochizuki M
Jpn J Cancer Res; 1987 Aug; 78(8):833-9. PubMed ID: 3115930
[TBL] [Abstract][Full Text] [Related]
37. Macrophage colony-stimulating factor induces the growth and differentiation of normal pregnancy human cytotrophoblast cells and hydatidiform moles but does not induce the growth and differentiation of choriocarcinoma cells.
Saito S; Ibaraki T; Enomoto M; Ichijo M; Motoyoshi K
Jpn J Cancer Res; 1994 Mar; 85(3):245-52. PubMed ID: 8188522
[TBL] [Abstract][Full Text] [Related]
38. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
Shimizu T; Matsuura S; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
[TBL] [Abstract][Full Text] [Related]
39. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.
Marrs RP; Kletzky OA; Howard WF; Mishell DR
Am J Obstet Gynecol; 1979 Nov; 135(6):731-6. PubMed ID: 495673
[TBL] [Abstract][Full Text] [Related]
40. Failure of contraceptive steroids to modify human chorionic gonadotrophin secretion by hydatidiform mole tissue and choriocarcinoma cells in culture.
Gal D; Simpson ER; Porter JC; MacDonald PC; Buchsbaum HJ
Steroids; 1981 Jun; 37(6):663-71. PubMed ID: 7027540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
